ID   HECD1_HUMAN             Reviewed;        2610 AA.
AC   Q9ULT8; D3DS86; Q6P445; Q86VJ1; Q96F34; Q9UFZ7;
DT   12-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   15-MAR-2017, entry version 157.
DE   RecName: Full=E3 ubiquitin-protein ligase HECTD1;
DE            EC=2.3.2.26;
DE   AltName: Full=E3 ligase for inhibin receptor;
DE   AltName: Full=EULIR;
DE   AltName: Full=HECT domain-containing protein 1;
DE   AltName: Full=HECT-type E3 ubiquitin transferase HECTD1;
GN   Name=HECTD1; Synonyms=KIAA1131;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang H.;
RT   "EULIR is an E3 ubiquitin ligase for inhibin receptor.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-2027.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 443-2610, AND VARIANT
RP   PRO-2027.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1652-2610, AND VARIANT
RP   PRO-2027.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2091-2610.
RC   TISSUE=Muscle, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH IGSF1.
RX   PubMed=12421765; DOI=10.1101/gr.406902;
RA   Nakayama M., Kikuno R., Ohara O.;
RT   "Protein-protein interactions between large proteins: two-hybrid
RT   screening using a functionally classified library composed of long
RT   cDNAs.";
RL   Genome Res. 12:1773-1784(2002).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1488, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1760 AND SER-1772, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2318, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   STRUCTURE BY NMR OF 1266-1338.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of MIB-HERC2 domain in HECT domain containing
RT   protein 1.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Probable E3 ubiquitin-protein ligase which accepts
CC       ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a
CC       thioester and then directly transfers the ubiquitin to targeted
CC       substrates. May be required for development of the head mesenchyme
CC       and neural tube closure. {ECO:0000250|UniProtKB:Q69ZR2}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with IGSF1. {ECO:0000269|PubMed:12421765}.
CC   -!- SIMILARITY: Belongs to the UPL family. K-HECT subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY254380; AAP13073.1; -; mRNA.
DR   EMBL; AL121808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136418; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65950.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65952.1; -; Genomic_DNA.
DR   EMBL; AB032957; BAA86445.2; -; mRNA.
DR   EMBL; AL110222; CAB53681.1; -; mRNA.
DR   EMBL; BC011658; AAH11658.2; -; mRNA.
DR   EMBL; BC063686; AAH63686.1; -; mRNA.
DR   CCDS; CCDS41939.1; -.
DR   PIR; T14761; T14761.
DR   RefSeq; NP_056197.3; NM_015382.3.
DR   RefSeq; XP_005267559.2; XM_005267502.2.
DR   UniGene; Hs.708017; -.
DR   PDB; 2DK3; NMR; -; A=1266-1338.
DR   PDB; 2LC3; NMR; -; A=1879-1966.
DR   PDB; 3DKM; X-ray; 1.60 A; A=1271-1341.
DR   PDBsum; 2DK3; -.
DR   PDBsum; 2LC3; -.
DR   PDBsum; 3DKM; -.
DR   ProteinModelPortal; Q9ULT8; -.
DR   SMR; Q9ULT8; -.
DR   BioGrid; 117359; 53.
DR   DIP; DIP-31669N; -.
DR   IntAct; Q9ULT8; 19.
DR   MINT; MINT-6783566; -.
DR   STRING; 9606.ENSP00000382269; -.
DR   iPTMnet; Q9ULT8; -.
DR   PhosphoSitePlus; Q9ULT8; -.
DR   BioMuta; HECTD1; -.
DR   DMDM; 313104227; -.
DR   EPD; Q9ULT8; -.
DR   MaxQB; Q9ULT8; -.
DR   PaxDb; Q9ULT8; -.
DR   PeptideAtlas; Q9ULT8; -.
DR   PRIDE; Q9ULT8; -.
DR   Ensembl; ENST00000399332; ENSP00000382269; ENSG00000092148.
DR   Ensembl; ENST00000553700; ENSP00000450697; ENSG00000092148.
DR   GeneID; 25831; -.
DR   KEGG; hsa:25831; -.
DR   UCSC; uc001wrc.1; human.
DR   CTD; 25831; -.
DR   GeneCards; HECTD1; -.
DR   HGNC; HGNC:20157; HECTD1.
DR   HPA; HPA002929; -.
DR   HPA; HPA054461; -.
DR   neXtProt; NX_Q9ULT8; -.
DR   PharmGKB; PA134989284; -.
DR   eggNOG; KOG4276; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   HOGENOM; HOG000018061; -.
DR   HOVERGEN; HBG067533; -.
DR   InParanoid; Q9ULT8; -.
DR   KO; K12231; -.
DR   PhylomeDB; Q9ULT8; -.
DR   TreeFam; TF323674; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; HECTD1; human.
DR   EvolutionaryTrace; Q9ULT8; -.
DR   GenomeRNAi; 25831; -.
DR   PRO; PR:Q9ULT8; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000092148; -.
DR   CleanEx; HS_HECTD1; -.
DR   ExpressionAtlas; Q9ULT8; baseline and differential.
DR   Genevisible; Q9ULT8; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:InterPro.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 1.25.10.10; -; 2.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR010606; Mib_Herc2.
DR   InterPro; IPR012919; SUN_dom.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF06701; MIB_HERC2; 1.
DR   Pfam; PF07738; Sad1_UNC; 1.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00119; HECTc; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56204; SSF56204; 4.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS51416; MIB_HERC2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Complete proteome; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation pathway.
FT   CHAIN         1   2610       E3 ubiquitin-protein ligase HECTD1.
FT                                /FTId=PRO_0000083945.
FT   REPEAT      395    424       ANK 1.
FT   REPEAT      426    455       ANK 2.
FT   REPEAT      459    491       ANK 3.
FT   REPEAT      579    612       ANK 4.
FT   DOMAIN     1266   1338       MIB/HERC2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00749}.
FT   DOMAIN     2151   2610       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   REGION     2029   2103       K-box.
FT   COMPBIAS   1350   1649       Ser-rich.
FT   ACT_SITE   2579   2579       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00104}.
FT   MOD_RES     631    631       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     640    640       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69ZR2}.
FT   MOD_RES    1384   1384       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69ZR2}.
FT   MOD_RES    1488   1488       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1567   1567       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69ZR2}.
FT   MOD_RES    1760   1760       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1772   1772       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2318   2318       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     656    656       Q -> H (in dbSNP:rs11620816).
FT                                /FTId=VAR_059666.
FT   VARIANT    2027   2027       L -> P (in dbSNP:rs1315794).
FT                                {ECO:0000269|PubMed:10574461,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_067707.
FT   CONFLICT    561    561       K -> Q (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT    603    603       L -> I (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT    611    613       FLD -> YKH (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT    653    653       K -> Q (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT    894    894       E -> K (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT    927    944       SMDLDMKQDCSQLVERIN -> VSIFRATKQKQNEVPKVIL
FT                                S (in Ref. 1; AAP13073). {ECO:0000305}.
FT   CONFLICT    951    951       S -> T (in Ref. 1; AAP13073).
FT                                {ECO:0000305}.
FT   CONFLICT   1281   1281       I -> T (in Ref. 2; BAA86445).
FT                                {ECO:0000305}.
FT   HELIX      1270   1272       {ECO:0000244|PDB:2DK3}.
FT   STRAND     1279   1282       {ECO:0000244|PDB:3DKM}.
FT   TURN       1289   1292       {ECO:0000244|PDB:3DKM}.
FT   STRAND     1299   1301       {ECO:0000244|PDB:3DKM}.
FT   STRAND     1309   1314       {ECO:0000244|PDB:3DKM}.
FT   TURN       1315   1317       {ECO:0000244|PDB:2DK3}.
FT   STRAND     1319   1325       {ECO:0000244|PDB:3DKM}.
FT   HELIX      1326   1328       {ECO:0000244|PDB:3DKM}.
FT   STRAND     1332   1334       {ECO:0000244|PDB:3DKM}.
FT   HELIX      1883   1886       {ECO:0000244|PDB:2LC3}.
FT   HELIX      1896   1902       {ECO:0000244|PDB:2LC3}.
FT   STRAND     1905   1908       {ECO:0000244|PDB:2LC3}.
FT   HELIX      1910   1920       {ECO:0000244|PDB:2LC3}.
FT   HELIX      1923   1928       {ECO:0000244|PDB:2LC3}.
FT   HELIX      1935   1941       {ECO:0000244|PDB:2LC3}.
FT   HELIX      1944   1957       {ECO:0000244|PDB:2LC3}.
FT   TURN       1960   1962       {ECO:0000244|PDB:2LC3}.
SQ   SEQUENCE   2610 AA;  289384 MW;  27E56401E07E158C CRC64;
     MADVDPDTLL EWLQMGQGDE RDMQLIALEQ LCMLLLMSDN VDRCFETCPP RTFLPALCKI
     FLDESAPDNV LEVTARAITY YLDVSAECTR RIVGVDGAIK ALCNRLVVVE LNNRTSRDLA
     EQCVKVLELI CTRESGAVFE AGGLNCVLTF IRDSGHLVHK DTLHSAMAVV SRLCGKMEPQ
     DSSLEICVES LSSLLKHEDH QVSDGALRCF ASLADRFTRR GVDPAPLAKH GLTEELLSRM
     AAAGGTVSGP SSACKPGRST TGAPSTTADS KLSNQVSTIV SLLSTLCRGS PVVTHDLLRS
     ELPDSIESAL QGDERCVLDT MRLVDLLLVL LFEGRKALPK SSAGSTGRIP GLRRLDSSGE
     RSHRQLIDCI RSKDTDALID AIDTGAFEVN FMDDVGQTLL NWASAFGTQE MVEFLCERGA
     DVNRGQRSSS LHYAACFGRP QVAKTLLRHG ANPDLRDEDG KTPLDKARER GHSEVVAILQ
     SPGDWMCPVN KGDDKKKKDT NKDEEECNEP KGDPEMAPIY LKRLLPVFAQ TFQQTMLPSI
     RKASLALIRK MIHFCSEALL KEVCDSDVGH NLPTILVEIT ATVLDQEDDD DGHLLALQII
     RDLVDKGGDI FLDQLARLGV ISKVSTLAGP SSDDENEEES KPEKEDEPQE DAKELQQGKP
     YHWRDWSIIR GRDCLYIWSD AAALELSNGS NGWFRFILDG KLATMYSSGS PEGGSDSSES
     RSEFLEKLQR ARGQVKPSTS SQPILSAPGP TKLTVGNWSL TCLKEGEIAI HNSDGQQATI
     LKEDLPGFVF ESNRGTKHSF TAETSLGSEF VTGWTGKRGR KLKSKLEKTK QKVRTMARDL
     YDDHFKAVES MPRGVVVTLR NIATQLESSW ELHTNRQCIE SENTWRDLMK TALENLIVLL
     KDENTISPYE MCSSGLVQAL LTVLNNSMDL DMKQDCSQLV ERINVFKTAF SENEDDESRP
     AVALIRKLIA VLESIERLPL HLYDTPGSTY NLQILTRRLR FRLERAPGET ALIDRTGRML
     KMEPLATVES LEQYLLKMVA KQWYDFDRSS FVFVRKLREG QNFIFRHQHD FDENGIIYWI
     GTNAKTAYEW VNPAAYGLVV VTSSEGRNLP YGRLEDILSR DNSALNCHSN DDKNAWFAID
     LGLWVIPSAY TLRHARGYGR SALRNWVFQV SKDGQNWTSL YTHVDDCSLN EPGSTATWPL
     DPPKDEKQGW RHVRIKQMGK NASGQTHYLS LSGFELYGTV NGVCEDQLGK AAKEAEANLR
     RQRRLVRSQV LKYMVPGARV IRGLDWKWRD QDGSPQGEGT VTGELHNGWI DVTWDAGGSN
     SYRMGAEGKF DLKLAPGYDP DTVASPKPVS STVSGTTQSW SSLVKNNCPD KTSAAAGSSS
     RKGSSSSVCS VASSSDISLG STKTERRSEI VMEHSIVSGA DVHEPIVVLS SAENVPQTEV
     GSSSSASTST LTAETGSENA ERKLGPDSSV RTPGESSAIS MGIVSVSSPD VSSVSELTNK
     EAASQRPLSS SASNRLSVSS LLAAGAPMSS SASVPNLSSR ETSSLESFVR RVANIARTNA
     TNNMNLSRSS SDNNTNTLGR NVMSTATSPL MGAQSFPNLT TPGTTSTVTM STSSVTSSSN
     VATATTVLSV GQSLSNTLTT SLTSTSSESD TGQEAEYSLY DFLDSCRAST LLAELDDDED
     LPEPDEEDDE NEDDNQEDQE YEEVMILRRP SLQRRAGSRS DVTHHAVTSQ LPQVPAGAGS
     RPIGEQEEEE YETKGGRRRT WDDDYVLKRQ FSALVPAFDP RPGRTNVQQT TDLEIPPPGT
     PHSELLEEVE CTPSPRLALT LKVTGLGTTR EVELPLTNFR STIFYYVQKL LQLSCNGNVK
     SDKLRRIWEP TYTIMYREMK DSDKEKENGK MGCWSIEHVE QYLGTDELPK NDLITYLQKN
     ADAAFLRHWK LTGTNKSIRK NRNCSQLIAA YKDFCEHGTK SGLNQGAIST LQSSDILNLT
     KEQPQAKAGN GQNSCGVEDV LQLLRILYIV ASDPYSRISQ EDGDEQLQFT FPPDEFTSKK
     ITTKILQQIE EPLALASGAL PDWCEQLTSK CPFLIPFETR QLYFTCTAFG ASRAIVWLQN
     RREATVERTR TTSSVRRDDP GEFRVGRLKH ERVKVPRGES LMEWAENVMQ IHADRKSVLE
     VEFLGEEGTG LGPTLEFYAL VAAEFQRTDL GAWLCDDNFP DDESRHVDLG GGLKPPGYYV
     QRSCGLFTAP FPQDSDELER ITKLFHFLGI FLAKCIQDNR LVDLPISKPF FKLMCMGDIK
     SNMSKLIYES RGDRDLHCTE SQSEASTEEG HDSLSVGSFE EDSKSEFILD PPKPKPPAWF
     NGILTWEDFE LVNPHRARFL KEIKDLAIKR RQILSNKGLS EDEKNTKLQE LVLKNPSGSG
     PPLSIEDLGL NFQFCPSSRI YGFTAVDLKP SGEDEMITMD NAEEYVDLMF DFCMHTGIQK
     QMEAFRDGFN KVFPMEKLSS FSHEEVQMIL CGNQSPSWAA EDIINYTEPK LGYTRDSPGF
     LRFVRVLCGM SSDERKAFLQ FTTGCSTLPP GGLANLHPRL TVVRKVDATD ASYPSVNTCV
     HYLKLPEYSS EEIMRERLLA ATMEKGFHLN
//
